Alzheon Launches IPO to Fund Alzheimer's Drug
Heron Therapeutics Soars on Positive Phase III Results
Study Reveals Huge Potential for mRNA Drug Targets
New Study Indicates DNA Plays Role in Gender Identity
Cidara Touts Positive Phase II Antifungal Data
Denali Therapeutics Adds $155 Million from Takeda
6 Biotech Companies with Upside Potential